Transcatheter Aortic Heart Valve Devices Market Snapshot
Published June 2023 | 10 Pages | 5 Exhibits | Forecasts Through 2027
Order individually or subscribe and get a complete intel platform.
Overview
This market snapshot from Life Science Intelligence provides an analysis of the global market for transcatheter aortic heart valve devices. These solutions are used as an alternative to surgical valve devices to repair or replace diseased aortic valve tissue. Devices covered within the scope of this analysis include transcatheter aortic valve repair and replacement devices.
This market snapshot is intended to provide a high-level overview of the global TAVR/TAVI market, with key insights into:
- Unit volumes from 2022 to 2027
- Market forecasts from 2022 to 2027
- Competitive landscape analysis of major competitors
- Insights into key market events for strategics and startups
Companies Covered
Abbott
Anteris
Colibri Heart Valve
Edwards Lifesciences
Genesis MedTech
JenaValve Technologies
Medtronic
NVT
ValVention
Vascular Innovations
Ready to get started?
Our trusted team is here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media. Get in touch today.
